Scientific News


News from the global scientific community focused on furthering the understanding and treatment of pediculosis, including research and clinical trials.

New Paper on Insecticide Resistance in Head Lice

A newly-published review paper in the April 2012 edition of Clinical Microbiological Infection discusses the spread of insecticide resistance and the effect on head lice treatment.

Ovidical testing of NYDA dimeticone treatment

A new study of the NYDA dimeticone series, published in the March 2012 edition of the Journal of Medical Entomology, has shown complete ovidical effectiveness in in vitro experiments.

Large-scale survey recommends more frequent lice inspections

A  large-scale survey of household lice inspection in Norway has found that nearly half of households inspect for head lice either biannually or not at all.

Pediculosis in the literature: brief update

Pediculosis is the subject of two new recent comment papers (subscription required for access).

Oral ivermectin, malathion and other treatments: literature roundup

A round-up of literature over the last couple of years covering diverse methods of treating pediculosis.

Dimeticones and pediculosis: a review of recent literature

Physically acting pedulicides are of continuing interest to the those creating and providing anti-head lice treatments. In particular, dimeticones have received increasing attention over the last few years. Here we summarise the results in the scientific literature between 2010 and now.

New Cochrane treatment review forthcoming

The Cochrane Collaboration has released an updated protocol for assessing the effectiveness of head-lice treatments by means of meta-studies of Randomized Controlled Trials, as part of an update to their review of evidence for the effectiveness of pediculosis treatments. 

New treatment modality ideas: insecticidal plastic surfaces

Could anti-headlice shower caps be the future for headlice treatment?

Spinosad in recent scientific literature

Spinosad has been the topic of two recent papers investigating its effectiveness in treating pediculosis in humans.

FDA grants approval to Sanofi-Topaz Sklice treatment

The FDA have granted approval on Tuesday 7 February 2012 to Sklice® lotion, the ivermectin-based topical treatment produced by Topaz Pharmaceuticals, now part of Sanofi Pasteur US.

Site Map   |    Privacy Policy   |   Terms & Conditions

© 2012-2013 — all rights reserved